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The Polytetrafluoroethylene (PTFE) Graft for Portacaval
Interposition: An Experimental Observationt
Alexander G. Yap, MD,* George Isshak, MD,* Ronald Lam, MD,** and Roger F. Smith, MD''

In an attempt to determine the efficacy of the polytetrafluoroethylene (PTFE) graft as a portacaval interposition shunt, 26 mongrel dogs were randomly selected to
receive a side-to-side shunt with a 6 mm, 8 mm, or 10 mm
PTFE graft after portal hypertension had been created by
hepatic vein ligation. The dogs were clinically observed,
and if they showed signs of graft occlusion, they were reexplored surgically. The 6 mm graft had aO% patency rate;

the 8 mm graft had a 28.6% patency rate; and the 10 mm
graft had an 87.5% patency rate. Histological examinations
revealed adequate incorporation of the graft, formation of
an endothelial layer, and absence of a thick intimal layer.
In this experimental model, the PTFE graft served as a
satisfactory portacaval interposition shunt when the 10 mm
graft was used.

r olytetrafluororethylene (PTFE) grafts have been extensively used clinically during the last several years as arterial
substitutes (1,2) and in isolated instances as venous substitutes (3-6). However, their use as venous substitutes has
never been universally accepted because of the low patency rates, due primarily to the lower pressure and slower
blood flow that characterizes the venous system. Drapanas
and Lord have reported on their successful use of the teflon
and dacron prosthesis for portacaval interposition shunts in
cases of portal hypertension (7-11), and Rosenthal recently
reported on the clinical use of the PTFE graft as a mesocaval shunt in seven patients with portal hypertension (12).
However, there are no published reports on the experimental use of the PTFE graft as an interposition portacaval
shunt for portal hypertension. Therefore, we decided to
design an experimental animal model that would both
create acute portal hypertension and test the effectiveness
ofthe PTFE graft. We were also interested in evaluating the
effect of different sizes of grafts on the adequacy of the
portal decompression, the duration of the shunt patency,
and the histological characteristics o f t h e implant.

Materials and Methods
Twenty-six mongrel dogs of both sexes, weighing between
19 and 29 kg, were anesthetized with sodium thiamylal for
induction and halothane (0.1-1.5y2) for maintenance.
Through a midline abdominal incision, the liver, portal
vein, and inferior vena cava were exposed. The portal vein
and inferior vena cava pressures were determined intraoperatively so that normal base line values could be obtained. The hepatic veins were carefully dissected and
individually ligated using a technique similar to that described by Orloff, et al (13-15). After the last hepatic vein
had been ligated, the venous congestion of the liver and
intestines was immediately evident. Creation of portal hypertension was documented and recorded by measuring
portal venous pressure directly (Fig. 1).
The 26 dogs were then randomly assigned to four groups.
Group I received a standard side-to-side portacaval shunt.
Groups II, 111, and IV underwent a portacaval interposition
shunt with 6 mm, 8 mm, and 10 mm PTFE grafts, respectively. The length of the graft for all groups was kept
constant at about 1.5 cm. The portal decompressing effect
of the PTFE graft interposition shunt was measured by
determining the postshunt portal venous pressure (Fig. 1).
Postoperatively, the dogs were observed clinically on a
daily basis. Serum bilirubin, alkaline phosphatase, serum
glutamic-pyruvic transaminase (SGPT), and complete
blood counts were obtained on a predetermined scheclule.
The development of ascites was clinically assessed in all
animals. Venograms were selectively taken to determine
the patency of the graft.
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Table I
CHANGE IN PORTAL PRESSURE FOLLOWING HEPATIC VEIN
LIGATION AND INTERPOSITION PORTACAVAL SHUNT
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Group I
Side-to-Side Shunt

Graft Diameter
Ascites

Shunt
Patency

1

None

2

Follow-up
(Weeks)

Final
Outcome

Open

8

Sacrificed

None

Open

20

Sacrificed

3

None
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4

None

Open

20

Sacrificed

5

None

Open

16

Sacrificed
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Table II
Group II
6 mm Diameter P T F E Shunts
Normal

Hepatic Vein PTFE Shunt
Ligation

Ascites

Shunt
Patency

1

None

Occluded

<12

Died

Dog

Fig. 1
Portal pressure increases w i t h ligation of the hepatic veins and
returns to normal after the PTFE interposition shunt.

The dogs that survived the operation were randomly sacrificed during the next ten months. Those that manifested
signs of late graft thrombosis, such as ascites, were reexplored. Three dogs were followed for at least ten months
in order to evaluate the long-term patency and histological
characteristics of the graft. All grafts were retrieved during
the postmortem examinations and sent for microscopic
pathological evaluation.

Foilow-up
(Hours)

Final
Outcome

2

None

Occluded

<12

Died

3

None

Occluded

<12

Died

4

None

Occluded

<12

Died

5

None

Occluded

<12

Died

6

None

Occluded

<12

Died

Table III
Group III
8 mm Diameter P T F E Shunts
Shunt
Patency

Follow-up
(Weeks)

Final
Outcome

16

Sacrificed

Results

Dogs

Table I gives the results for the first group of dogs with sideto-side portacaval shunts, which served as the control
group. One dog died postoperatively within the first 24
hours. The four remaining animals all had patent shunts up
to a maximum period of five months of follow-up.

1

None

Occluded

2

None

Occluded

< 1 day

Died

3

None

Occluded

< 1 day

Died

4

None

Open

5

Yes

6

None

7

None

Open

In Group II, composed of dogs with 6 mm PTFE interposition shunts, all six PTFE grafts occluded during the first 24
hours after surgery (Table II). At autopsy, severe liver and
mesenteric venous congestion had resulted in scattered
areas of intestinal ischemia and infarction.
Among the seven dogs randomly assigned to the 8 mm
PTFE group, two died on the first postoperative day (Table
III). Again, the autopsy showed severe intestinal venous
congestion with areas of bowel necrosis. The grafts were
occluded. A third dog developed progressive ascites which
started t w o weeks postoperatively. This dog was reexplored on the 21st postoperative day, and approximately
4.5L of ascitic fluid was removed. The graft was collapsed
and occluded. The liver was grossly congested, but there
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Ascites

8

Sacrificed

Occluded

3

Sacrificed

Occluded

27

Sacrificed

8

Sacrificed

were no signs of intestinal ischemia or necrosis. The portal
pressure was elevated at 14 c m H j O . During the first operation on this dog the portal pressure was 16 c m H i O , but it
had been reduced to 3 cmH20 after the shunt. Closure of
the graft undoubtedly was responsible for the later increase
in portal pressure from 3 to 14 cmHsO.
Two other dogs were re-explored on the 60th and 67th
postoperative day, and both were found to have an open
graft. Two more dogs were followed for four and nine
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before re-exploration on the 53rd postoperative day. The
operative findings were similar to those found in the 8 mm
graft dog with ascites: the graft was completely occluded.
All other dogs with 10 mm PTFE grafts had open grafts.
Venograms were performed selectively to demonstrate
shunt patency (Fig. 2).

Table IV
Group IV
10 mm Diameter PTFE Grants
Dog

Ascites

Shunt
Patency

Follow-up
(Weeks)

Final
Outcome

1

Yes

Occluded

8

Sacrificed

2

None

Open

14

Sacrificed

3

None

Open

44

Sacrificed

4

None

Open

.44

Sacrificed

5

None

Open

1

When the grafts were recovered within four months or less,
no significant gross changes were detectable. Microscopic
examination revealed some red blood cells and a few
monocytes and leukocytes within the wall. After the 90th
postoperative day, microscopic examination revealed proliferation of spindle-shaped fibroblasts and small blood
vessels within the graft wall, as well as scattered mononuclear cells of histiocytic origin with rare Langhan foreign
body giant cells. All ten patent grafts were endothelialized
with a layer of acquired fibrous intima of variable thickness. One also showed microscopic foci of calcification.

Died
(Distemper)

6

None

Open

7

None

8

None

11

Sacrificed

Open

4

Sacrificed

Open

12

Sacrificed

Afterthe fourth month of implantation, areas of patchy and
extensive calcium depositions in the wall of the grafts were
seen grossly and were more evident in the older grafts. The
older grafts also appeared thick, hard, and gritty on cut
sections. Microscopic examination revealed a more extensive cellular reaction consisting of fibroblastic cells and
endothelial proliferations with collagen and fibrous tissue
deposited within the wall of the grafts. A single layer of flat
endothelial cells (Fig. 3) was seen among the 10 mm grafts
that were followed for up to ten months. None of the long-

Fig. 2
Venogram showing patent portacaval PTFE graft (10 mm) at 80 days
after implantation.

months, respectively. The grafts in both these dogs were
found to be occluded on re-exploration, but no ascites or
other signs of liver or intestinal congestion were found.
In Group IV, none ofthe 10 mm grafts closed immediately,
and none of the dogs died during the early postoperative
period (Table IV). One dog developed ascites three weeks
after the first operation. Abdominal paracentesis had to be
performed twice to relieve the tense, enlarging abdomen

Fig. 3
Photomicrograph of 10 mm PTFE graft ten months after Implantation showing the endothelial layer (E), intimal layer (I), and calcifications (C). 72 X (H & E)
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term grafts demonstrated any histologic evidence ofa thick
pseudo-intimal layer.

Patency Rate of PTFE Grafts
According to Diameter

No significant changes in the serum bilirubin, alkaline
phosphatase, or total serum protein became evident during
the study.

100'

Discussion
80-

To carry out the aims of our study on PTFE grafts, it was
necessary to develop an animal model of portal hypertension. This was accomplished by complete ligation of the
hepatic veins, which, in turn, immediately resulted in
severe hypertension in all dogs. During the same operation, the PTFE portacaval interposition was performed because the acute hypertension would lead to mesenteric
thrombosis and death, as seen in the immediately closed
grafts. This method also eliminated any morbidity associated w i t h subjecting the animals to t w o separate
operations.

c

'
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o
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Immediate occlusion of the graft always led to early death,
because the sudden increase of portal pressure without the
decompressing effect of an interposition shunt could notbe
tolerated. The development of ascites from the second to
about the eighth week postoperatively was a strong indication of delayed graft thrombosis. Two dogs developed
ascites in their second and third postoperative week, and
both of these grafts were occluded. However, when the
dogs were followed for more than four months, late occlusion of the graft did not produce ascites. The formation of
adequate collateral circulation was undoubtedly responsible for the animal's ability to tolerate late graft occlusion
without ascites formation. Of four dogs that were followed
from four to ten months, two had an open graft of the 10
mm graft size, and two had occluded grafts of the 8 mm
size but without ascites (Table IV).

DIAMETER PTFE GRAFT

Fig. 4

While dacron and teflon grafts used in the venous system
have a high incidence of neo-intimal layering that narrows
the inner lumen of the graft (8), we have not found any
evidence of a thick intimal layer among the PTFE grafts that
we studied microscopically. This suggests an additional
advantage of the PTFE graft over other synthetic materials;
however, longer follow-up studies ofthe PTFE graft in vivo
will be necessary.

Ofthe three sizes of grafts used, the 10 mm graft performed
best (Fig. 4). Only one of the eight dogs in this group
occluded after the second postoperative week. All other
grafts continued to remain patent for as long as ten months.
The excellent patency rate for this group parallels that of
our control group, which had a side-to-side portacaval
shunt and no interposition graft. Performance of the 6 mm
graft was very disappointing, with all animals in this group
dying due to early graft occlusion. This graft invariably
occluded within the first 24 hours postoperatively.

There is little doubt that an autogenous vein interposition
graft, such as the jugular vein, is superior to synthetic
materials (16,17). However, if the effectiveness of the PTFE
graft can be shown to compare favorably to that of the vein
graft, then the PTFE graft would have an advantage in most
clinical situations, since operative time and surgical stress
would be reduced by eliminating the vein harvesting.

The significance ofthe increasing deposition of calcium in
the walls of the graft according to its length of implantation
is difficult to determine. However, the presence of an
endothelial layer certainly is encouraging because of its
well-known ability to resist thrombus formation. With a
large diameter PTFE graft, such a layer should lead to a
favorable long-term patency rate.

Our findings have demonstrated that the larger the size of
the interposition graft, the better the patency rate. The 10
mm diameter PTFE graft had a 87.5% patency rate when
followed either on a short or longer-term basis. We therefore conclude that the PTFE graft performs adequately as a
portacaval interposition shunt in the dog if a 10 mm
diameter graft is used.

Conclusions
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